Concepedia
Statistics
Publications
8
Citations
657
H-Index
Active since
2000
Affiliations
AbbVie (United States)(Current)
Harvard University
Massachusetts General Hospital
Brigham and Women's Hospital
Lorenzo Benatuil is an author at AbbVie (United States) specializing in immunology, pharmacology, and antibody characterization.
Publications per year
2000–2019
An improved yeast transformation method for the generation of very large human antibody libraries
Lorenzo Benatuil, Jennifer M. Perez, Jonathan Belk et al. · Protein Engineering Design and Selection · 2010 · 465 citations
Pharmacy, Biotechnology, Molecular Biology +17
Characterization of ABBV-221, a Tumor-Selective EGFR-Targeting Antibody Drug Conjugate
Andrew C. Phillips, Erwin R. Boghaert, Kedar S. Vaidya et al. · Molecular Cancer Therapeutics · 2018 · 52 citations · Full text
Medicine, Oncology, Pharmacology +17
The influence of natural antibody specificity on antigen immunogenicity
Lorenzo Benatuil, Joel Kaye, Robert F. Rich et al. · European Journal of Immunology · 2005 · 40 citations · Full text
Life Sciences, Immunology, Adaptive Immunity +16
CD40/anti-CD40 antibody complexes which illustrate agonist and antagonist structural switches
M.A. Argiriadi, Lorenzo Benatuil, I. Dubrovska et al. · BMC Molecular and Cell Biology · 2019 · 30 citations · Full text
Pharmacy, Immunology, Molecular Biology +14
Generation and characterization of ABBV642, a dual variable domain immunoglobulin molecule (DVD-Ig) that potently neutralizes VEGF and PDGF-BB and is designed for the treatment of exudative age-related macular degeneration
Kun Ding, Lucia J. Eaton, Diana R. Bowley et al. · mAbs · 2016 · 24 citations · Full text
Medicine, Ophthalmology, Vision Science +17
1–5 of 8